ArticleTherapeutic advances in medical oncology2026

Real-world outcomes of trastuzumab deruxtecan in patients with HER2+ metastatic breast cancer: Turkish oncology group multicenter study.

Taha Koray Sahin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.